Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Repligen Corporation (RGEN) Profit Margins

Over the twelve months to 2026-06-30, Repligen Corporation (RGEN) had gross margin 53.8%, operating margin 8.2%, net margin 5.3%, free cash flow margin 14.0%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RGENRepligen CorporationFollow RGEN — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
10.0B
P/E TTM
242.4
Dividend yield
—
52-week
—
Next earnings
27 Oct, in 3 days
LineFY2011
Mar 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin79.6%59.9%67.0%55.9%57.8%54.9%52.5%55.4%55.9%57.2%58.3%56.9%44.0%43.3%52.3%53.8%
Operating margin-1.4%17.8%33.6%16.8%16.5%15.3%9.9%13.4%13.4%19.1%24.9%28.0%7.5%-5.5%7.5%8.2%
Net margin-0.2%22.7%23.6%12.9%11.2%11.2%20.1%8.6%7.9%16.4%19.1%23.2%5.6%-4.0%6.6%5.3%
FCF margin9.9%19.6%31.2%20.1%14.9%3.1%8.5%10.3%16.3%9.9%7.1%10.4%11.8%22.9%12.4%14.0%

USD billions · SEC XBRL

Repligen Corporation — questions

What is Repligen Corporation's gross margin?
53.8% over the twelve months to 2026-06-30.
What is Repligen Corporation's operating margin?
8.2% over the twelve months to 2026-06-30.
What is Repligen Corporation's net profit margin?
5.3% over the twelve months to 2026-06-30.

Every figure on this page comes from Repligen Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.